AbbVie Pty Ltd
Regulatory activities for this sponsor.
Loading...
Sponsor content
285 result(s) found, displaying 61 to 70
-
Cancellation by sponsorRequested by Abbvie Pty Ltd
-
Cancellation by sponsorRequested by Abbvie Pty Ltd
-
Cancellation by sponsorRequested by Abbvie Pty Ltd
-
Cancellation by sponsorRequested by Abbvie Pty Ltd
-
Cancellation by sponsorRequested by Abbvie Pty Ltd
-
Cancellation by sponsorRequested by Abbvie Pty Ltd
-
Cancellation by sponsorRequested by Abbvie Pty Ltd
-
Australian Public Assessment Report (AusPAR)AusPAR for RINVOQ (Upadacitinib) for treatment of atopic dermatitis in patients aged 12 years and above.
-
Australian Public Assessment Report (AusPAR)AusPAR for Maviret (glecaprevir /pibrentasvir) for the treatment of adult and paediatric patients with chronic hepatitis C virus.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for MAVIRET glecaprevir 50 mg / pibrentasvir 20 mg granules sachet.